Literature DB >> 17031829

Low viscosity histidine-tryptophan-ketoglutarate graft flush improves subsequent extended cold storage in University of Wisconsin solution in an extracorporeal rat liver perfusion and rat liver transplantation model.

Gero Puhl1, Peter Olschewski, Wenzel Schöning, Gerhard Hunold, Hans-Georg Liesaus, Robert Winkler, Ulf P Neumann, Thomas E O Schubert, Volker Schmitz, Peter Neuhaus.   

Abstract

Adequate flushing for liver donation requires large fluid volumes delivered at a high flow. This can be achieved more effectively with crystalloid solutions than with colloid-based solutions. This study examined the combination of initial histidine-tryptophan-ketoglutarate solution (HTK) graft flush and subsequent storage in University of Wisconsin solution (UW) to that of the single use of each solution. Livers from inbred Wistar rats were procured using aortic perfusion with UW or HTK for initial perfusion and reflushed after 30 minutes using either solution. In a third group, after perfusion with HTK, organs were reflushed with UW. A 60-minute in-vitro recirculating perfusion was performed after 24 hours of cold storage in the subsequent solution, as well as allotransplantation after 18 and 24 hours of cold storage. In extracorporeal perfusion, the HTK flush followed by UW storage was superior compared to the single use of either UW or HTK solution, as measured by portal venous pressure, bile flow, liver enzymes released into the effluent perfusate, glycerol leakage, and histological examinations. These data were consistent with the transplantation study. Histological damage and enzyme release after 5-day survival were lowest in the HTK flush and subsequent UW storage groups following 18 hours of cold storage; likewise, the 5-day survival was superior following 24 hours of cold storage. In conclusion, the combined use of HTK solution for initial graft rinse and subsequent storage in UW solution resulted in a cumulative protection. Choosing low-viscosity HTK solution for the initial organ flush may represent a feasible improvement in liver preservation, which also further reduces the required amount of UW solution.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17031829     DOI: 10.1002/lt.20913

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  6 in total

1.  Experimental small bowel preservation using Polysol: a new alternative to University of Wisconsin solution, Celsior and histidine-tryptophan-ketoglutarate solution?

Authors:  Lai Wei; Koichiro Hata; Benedict-Marie Doorschodt; Reinhard Büttner; Thomas Minor; René H Tolba
Journal:  World J Gastroenterol       Date:  2007-07-21       Impact factor: 5.742

2.  Celsior versus University of Wisconsin preserving solutions for liver transplantation: postreperfusion syndrome and outcome of a 5-year prospective randomized controlled study.

Authors:  Francisco A García-Gil; María T Serrano; Lorena Fuentes-Broto; Juan Arenas; José J García; Antonio Güemes; Vanesa Bernal; Ana Campillo; Carlos Sostres; Juan J Araiz; Pablo Royo; Miguel A Simón
Journal:  World J Surg       Date:  2011-07       Impact factor: 3.352

3.  Hepatocyte viability and adenosine triphosphate content decrease linearly over time during conventional cold storage of rat liver grafts.

Authors:  T A Berendsen; M L Izamis; H Xu; Q Liu; M Hertl; F Berthiaume; M L Yarmush; K Uygun
Journal:  Transplant Proc       Date:  2011-06       Impact factor: 1.066

4.  Surgical procedures for a rat model of partial orthotopic liver transplantation with hepatic arterial reconstruction.

Authors:  Kazuyuki Nagai; Shintaro Yagi; Shinji Uemoto; Rene H Tolba
Journal:  J Vis Exp       Date:  2013-03-07       Impact factor: 1.355

Review 5.  Melatonin role preventing steatohepatitis and improving liver transplantation results.

Authors:  Eduardo Esteban-Zubero; Francisco Agustín García-Gil; Laura López-Pingarrón; Moisés Alejandro Alatorre-Jiménez; José Manuel Ramírez; Dun-Xian Tan; José Joaquín García; Russel J Reiter
Journal:  Cell Mol Life Sci       Date:  2016-03-29       Impact factor: 9.261

6.  Ischemia-Reperfusion Injury and Ischemic-Type Biliary Lesions following Liver Transplantation.

Authors:  Raffaele Cursio; Jean Gugenheim
Journal:  J Transplant       Date:  2012-02-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.